Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
「Strategy Counterparty Liquidation」 Long Position Breakeven Closeout After Drawdown, Temporary Position Size Reduced by Approximately $80 Million

「Strategy Counterparty Liquidation」 Long Position Breakeven Closeout After Drawdown, Temporary Position Size Reduced by Approximately $80 Million

BlockBeatsBlockBeats2026/01/12 09:19

BlockBeats News, January 12, according to Hyperinsight monitoring, due to the short-term decline in BTC's price, the "Strategy Counterparty" whale address (0x94d) saw all 7 mainstream coins' long positions fall below the average entry price. Subsequently, the address closed all XRP and SOL long positions and gradually reduced other holdings. As of now, the address has liquidated over $80 million in a short period, reducing its total holdings from $351 million to $270 million.


The address started accumulating since December last year, with an initial $20 million account size, and then gradually increased short positions in mainstream coins such as BTC and ETH. Due to its strategy being the exact opposite of the publicly traded company MicroStrategy's continuous BTC accumulation, this address is seen by the market as a clear "on-chain counterpart."


The address's current main holdings are:


BTC 20x long, quantity: 1,712 coins, holding amount: $160 million, current loss: $260,000, current price: $91,000, liquidation price: $75,000;


ETH 20x long, quantity: 29,000 coins, holding amount: $90 million, current loss: $170,000, current price: $3,117, liquidation price: $2,194.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AstraZeneca (AZN.US) Q3 profit growth surpasses expectations, driven mainly by oncology drugs

AstraZeneca (AZN.US) released its Q3 2026 results on October 30th. At constant exchange rates (CER), total revenue for the quarter increased by 7% year-on-year to $16.209 billions.

智通财经•2026/10/30 08:18

BP.US Q3 profits soar to 18-year high: Refining business becomes 'money-printing machine', CEO's reforms encounter strong tailwind

Benefiting from a surge in refining profit margins, BP's quarterly profit jumped to its highest level in 18 years.

智通财经•2026/10/30 08:04